Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-21

FDA Approved: TOPIRAMATE — Supplemental Application (NorthStar RxLLC)

View source ↗

Summary

FDA approved a supplemental application for Topiramate (generic Topiramate) from NorthStar RxLLC under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topiramate (Topiramate)

Snippet

SUPPL AP for TOPIRAMATE (TOPIRAMATE)